← FDA DRUG APPROVALS

FDA ANDA · ANDA063294

CEFIZOX

Sponsor: ASTELLAS

APPLICATION
ANDA063294
TYPE
ANDA
ORIGINAL APPROVAL
1994-03-31
LATEST ACTION
2002-12-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFIZOXDiscontinued
CEFTIZOXIME SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
CEFIZOXDiscontinued
CEFTIZOXIME SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2002-12-23Manufacturing (CMC) · Supplement 5AP
2000-12-07Manufacturing (CMC) · Supplement 4AP
1996-03-29Manufacturing (CMC) · Supplement 1AP
1994-03-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →